{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:21:31Z","timestamp":1790061691934,"version":"4.0.1"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The higher incidence of thyroid cancer in women compared with men suggests an influence of sex steroid hormones in the etiology of this malignancy. We investigated a comprehensive set of potential indicators of lifetime sex steroid hormone exposure in relation to thyroid cancer risk. Using data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, which enrolled 70,047 women, 50 to 78 years old, we prospectively examined associations of self-reported history of benign breast and gynecologic conditions, reproductive factors, and exogenous sex hormone use with thyroid cancer risk. Multivariable-adjusted HRs and 95% confidence intervals (CI) were calculated in models using age as the time metric. During follow-up (median, 11 years), 127 women were diagnosed with first primary thyroid cancer. Older age at natural menopause (\u226555 vs. &amp;lt;50 years; HR, 2.24; 95% CI, 1.20\u20134.18), greater estimated lifetime number of ovulatory cycles (\u2265490 vs. &amp;lt;415 cycles; HR, 2.40; 95% CI, 1.33\u20134.30), greater number of live births (\u22655 vs. 1\u20132; HR, 1.72; 95% CI, 1.05\u20132.82), and history of uterine fibroids (HR, 1.72; 95% CI, 1.18\u20132.50) were associated with an increased risk of thyroid cancer. Earlier age at menarche, greater number of reproductive years, history of a tubal ligation, and history of ovarian cysts were nonsignificantly associated with increased thyroid cancer risk. No associations were observed for oral contraceptive use, menopausal hormone therapy, or history of benign breast disease or endometriosis. In general, we found that factors reflecting a greater length of exposure to endogenous hormones, particularly during the reproductive years, were associated with risk of postmenopausal thyroid cancer. Cancer Prev Res; 7(4); 418\u201325. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-13-0367","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T21:09:35Z","timestamp":1390338575000},"page":"418-425","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Benign Breast and Gynecologic Conditions, Reproductive and Hormonal Factors, and Risk of Thyroid Cancer"],"prefix":"10.1158","volume":"7","author":[{"given":"Melissa Z.","family":"Braganza","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Berrington de Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Schonfeld","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina V.","family":"Brenner","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari M.","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; and 2Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"2022060816235801300_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/acprof:oso\/9780195149616.003.0050","article-title":"Thyroid cancer","volume-title":"Cancer epidemiology and prevention","author":"Ron","year":"2006"},{"key":"2022060816235801300_bib2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2217\/fon.10.127","article-title":"Thyroid cancer gender disparity","volume":"6","author":"Rahbari","year":"2010","journal-title":"Future Oncol"},{"key":"2022060816235801300_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/156800908785133150","article-title":"Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer","volume":"8","author":"Chen","year":"2008","journal-title":"Current Cancer Drug Targets"},{"key":"2022060816235801300_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/thy.2009.0296","article-title":"Metastatic phenotype is regulated by estrogen in thyroid cells","volume":"20","author":"Rajoria","year":"2010","journal-title":"Thyroid"},{"key":"2022060816235801300_bib5","doi-asserted-by":"crossref","first-page":"e29177","DOI":"10.1371\/journal.pone.0029177","article-title":"BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review","volume":"7","author":"Peterson","year":"2012","journal-title":"PLOS ONE"},{"key":"2022060816235801300_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.mcna.2008.04.003","article-title":"Breast disease: benign and malignant","volume":"92","author":"Meisner","year":"2008","journal-title":"Med Clin North Am"},{"key":"2022060816235801300_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bpobgyn.2007.07.005","article-title":"Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment","volume":"22","author":"Petraglia","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2022060816235801300_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/kwp354","article-title":"Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study","volume":"171","author":"Meinhold","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2022060816235801300_bib9","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.canep.2011.05.009","article-title":"Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study","volume":"35","author":"Schonfeld","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"2022060816235801300_bib10","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/humrep\/dem209","article-title":"The risk of cancer and the role of parity among women with endometriosis","volume":"22","author":"Melin","year":"2007","journal-title":"Hum Reprod"},{"key":"2022060816235801300_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.ede.0000164812.02181.d5","article-title":"Causes of infertility as predictors of subsequent cancer risk","volume":"16","author":"Brinton","year":"2005","journal-title":"Epidemiology"},{"key":"2022060816235801300_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/oxfordjournals.epirev.a017960","article-title":"Epidemiology of benign breast disease, with special attention to histologic types","volume":"19","author":"Goehring","year":"1997","journal-title":"Epidemiol Rev"},{"key":"2022060816235801300_bib13","first-page":"764","article-title":"Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States","volume":"86","author":"Velebil","year":"1995","journal-title":"ObstetGynecol"},{"key":"2022060816235801300_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"2022060816235801300_bib15","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1055-9965.EPI-05-0394","article-title":"Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors","volume":"14","author":"Brinton","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816235801300_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/thy.2006.0330","article-title":"Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids","volume":"17","author":"Spinos","year":"2007","journal-title":"Thyroid"},{"key":"2022060816235801300_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1507\/endocrj.K10E-024","article-title":"The relationship between thyroid nodules and uterine fibroids","volume":"57","author":"Kim","year":"2010","journal-title":"Endocr J"},{"key":"2022060816235801300_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1542-2011.2012.00176.x","article-title":"Etiology, diagnosis, and management of uterine leiomyomas","volume":"57","author":"Rice","year":"2012","journal-title":"J Midwifery Women's Health"},{"key":"2022060816235801300_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"key":"2022060816235801300_bib20","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials"},{"key":"2022060816235801300_bib21","first-page":"1","article-title":"Cancer incidence in five continents","author":"IARC","year":"2008"},{"key":"2022060816235801300_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00051335","article-title":"The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom)","volume":"4","author":"De Stavola","year":"1993","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1055-9965.EPI-04-0465","article-title":"Postmenopausal breast cancer risk and cumulative number of menstrual cycles","volume":"14","author":"Chavez-MacGregor","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816235801300_bib24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","article-title":"Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer","volume":"89","author":"Schildkraut","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"2022060816235801300_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ijc.1377","article-title":"Cohort study of thyroid cancer in a San Francisco Bay area population","volume":"93","author":"Iribarren","year":"2001","journal-title":"Int J Cancer"},{"key":"2022060816235801300_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1008880429862","article-title":"A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors","volume":"10","author":"Negri","year":"1999","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/aje\/kwi136","article-title":"Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area","volume":"161","author":"Truong","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2022060816235801300_bib28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1055-9965.EPI-11-0381","article-title":"Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort","volume":"20","author":"Horn-Ross","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816235801300_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1008832513932","article-title":"A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones","volume":"10","author":"La Vecchia","year":"1999","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib30","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10552-012-0084-x","article-title":"Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women","volume":"23","author":"Kabat","year":"2012","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/09513590.2011.569606","article-title":"Factors connected with the female sex seem to play an important role in differentiated thyroid cancer","volume":"27","author":"Przybylik-Mazurek","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"2022060816235801300_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ije\/18.3.578","article-title":"Risk factors for thyroid cancer in northern Italy","volume":"18","author":"Franceschi","year":"1989","journal-title":"Int J Epidemiol"},{"key":"2022060816235801300_bib33","first-page":"1","article-title":"A population-based case-control study of thyroid cancer","volume":"79","author":"Ron","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"2022060816235801300_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2022060816235801300_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/oxfordjournals.aje.a010276","article-title":"Reproductive factors and risk of papillary thyroid cancer in women","volume":"151","author":"Rossing","year":"2000","journal-title":"Am J Epidemiol"},{"key":"2022060816235801300_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","article-title":"Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition","volume":"127","author":"Dossus","year":"2010","journal-title":"Int J Cancer"},{"key":"2022060816235801300_bib37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00404-013-2784-1","article-title":"Ovarian epithelial tumors and reproductive factors: a systematic review","volume":"287","author":"Schuler","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"2022060816235801300_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","article-title":"Reproductive factors and breast cancer","volume":"15","author":"Kelsey","year":"1993","journal-title":"Epidemiol Revi"},{"key":"2022060816235801300_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1023\/A:1020684821837","article-title":"Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women","volume":"13","author":"Clavel-Chapelon","year":"2002","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"key":"2022060816235801300_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1020678100977","article-title":"Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)","volume":"13","author":"Moorman","year":"2002","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"2022060816235801300_bib43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J","volume":"97","author":"Kaaks","year":"2005","journal-title":"Natl Cancer Inst"},{"key":"2022060816235801300_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00130404-200503000-00006","article-title":"Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL","volume":"11","author":"Lee","year":"2005","journal-title":"Cancer J"},{"key":"2022060816235801300_bib45","first-page":"67","article-title":"Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions","volume":"53","author":"Lewy-Trenda","year":"2002","journal-title":"Pol J Pathol"},{"key":"2022060816235801300_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00051793","article-title":"Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States)","volume":"6","author":"Hankinson","year":"1995","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5122(00)00105-5","article-title":"Reproductive history in relation to plasma hormone levels in healthy post-menopausal women","volume":"35","author":"Ness","year":"2000","journal-title":"Maturitas"},{"key":"2022060816235801300_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008929714862","article-title":"Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom)","volume":"12","author":"Verkasalo","year":"2001","journal-title":"Cancer Causes Control"},{"key":"2022060816235801300_bib49","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/1055-9965.1296.13.8","article-title":"Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations","volume":"13","author":"Chubak","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/4\/418\/3040712\/418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/4\/418\/3040712\/418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:51:41Z","timestamp":1716454301000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/7\/4\/418\/50306\/Benign-Breast-and-Gynecologic-Conditions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,1]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0367","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}